Human genetic studies linking ENPP1 mutations to increased FGF23 levels and subsequent hypophosphatemia (Lorenz-Depiereux et al., 2010) have recently been confirmed in an Enpp1−/− mouse model (Mackenzie et al., 2012b). Here, FGF23 is linked to hypophosphatemia.